Correlation Between Iovance Biotherapeutics and ABPRO P

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and ABPRO P at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and ABPRO P into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and ABPRO P, you can compare the effects of market volatilities on Iovance Biotherapeutics and ABPRO P and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of ABPRO P. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and ABPRO P.

Diversification Opportunities for Iovance Biotherapeutics and ABPRO P

0.7
  Correlation Coefficient

Poor diversification

The 3 months correlation between Iovance and ABPRO is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and ABPRO P in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABPRO P and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with ABPRO P. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABPRO P has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and ABPRO P go up and down completely randomly.

Pair Corralation between Iovance Biotherapeutics and ABPRO P

Given the investment horizon of 90 days Iovance Biotherapeutics is expected to generate 1.03 times more return on investment than ABPRO P. However, Iovance Biotherapeutics is 1.03 times more volatile than ABPRO P. It trades about 0.03 of its potential returns per unit of risk. ABPRO P is currently generating about -0.11 per unit of risk. If you would invest  782.00  in Iovance Biotherapeutics on September 14, 2024 and sell it today you would lose (6.00) from holding Iovance Biotherapeutics or give up 0.77% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.6%
ValuesDaily Returns

Iovance Biotherapeutics  vs.  ABPRO P

 Performance 
       Timeline  
Iovance Biotherapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Iovance Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
ABPRO P 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ABPRO P has generated negative risk-adjusted returns adding no value to investors with long positions. Even with inconsistent performance in the last few months, the Stock's fundamental drivers remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Iovance Biotherapeutics and ABPRO P Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Iovance Biotherapeutics and ABPRO P

The main advantage of trading using opposite Iovance Biotherapeutics and ABPRO P positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, ABPRO P can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABPRO P will offset losses from the drop in ABPRO P's long position.
The idea behind Iovance Biotherapeutics and ABPRO P pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Bonds Directory
Find actively traded corporate debentures issued by US companies
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets